CN Patent

CN103415313B — 注射器及注射器组装体

Assigned to Terumo Corp · Expires 2017-06-13 · 9y expired

What this patent protects

注射器具有外筒(2)、垫片(3)和推压件(4)。推压件(4)具有按压部(42)和筒状的把持部(41)，所述筒状的把持部(41)覆盖外筒(2)的外周的至少一部分并且设置成能够相对于外筒(2)在其长度方向上移动，所述按压部与把持部(41)连结并插入到外筒(2)内，并通过把持部(41)相对于外筒(2)向前端侧的移动使垫片(3)向前端侧移动。另外，在把持部(41)与外筒(2)之间设置有对把持部(41)相对于外筒(2)的移动进行引导的引导部。

USPTO Abstract

注射器具有外筒(2)、垫片(3)和推压件(4)。推压件(4)具有按压部(42)和筒状的把持部(41)，所述筒状的把持部(41)覆盖外筒(2)的外周的至少一部分并且设置成能够相对于外筒(2)在其长度方向上移动，所述按压部与把持部(41)连结并插入到外筒(2)内，并通过把持部(41)相对于外筒(2)向前端侧的移动使垫片(3)向前端侧移动。另外，在把持部(41)与外筒(2)之间设置有对把持部(41)相对于外筒(2)的移动进行引导的引导部。

Drugs covered by this patent

testosterone-enanthate (TESTOSTERONE ENANTHATE)

Patent Metadata

Patent number: CN103415313B
Jurisdiction: CN
Classification: —
Expires: 2017-06-13
Drug substance claim: No
Drug product claim: No
Assignee: Terumo Corp
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.